Believe it: Just as Amarin promised, Vascepa delivers big win in heart-risk study

24th September 2018 Uncategorised 0

Call it a promise kept. For years, Amarin has staunchly defended its heart drug Vascepa, despite detractors’ disbelief that the drug truly cut cardiovascular risks. According to a new study, it does—and in a big way.

More: Believe it: Just as Amarin promised, Vascepa delivers big win in heart-risk study
Source: fierce